selected publications
- Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma. Journal of medicinal chemistry. 2023 Academic Article GET IT
-
Identification of estrogen receptor down-regulators for endocrine resistant breast cancer.
The Journal of steroid biochemistry and molecular biology.
2022
Academic Article
GET IT
Times cited: 1 - Identification of Prazosin as a Potential Flagellum Attachment Zone 1(FAZ1) Inhibitor for the Treatment of Human African Trypanosomiasis. ACS infectious diseases. 2022 Academic Article GET IT
- Synthesis and biological evaluation of imidamide analogs as selective anti-trypanosomal agents. Bioorganic & medicinal chemistry. 2022 Academic Article GET IT
-
Pharmacokinetic and brain distribution study of an anti-glioblastoma agent in mice by HPLC-MS/MS.
Biomedical chromatography : BMC.
2022
Academic Article
GET IT
Times cited: 3 -
Distribution, Biotransformation, Pharmacological Effects, Metabolic Mechanism and Safety Evaluation of Platycodin D: A Comprehensive Review.
Current drug metabolism.
2022
Review
GET IT
Times cited: 7 - Pharmacokinetic study of an anti-trypanosome agent with different formulations and administration routes in mice by HPLC-MS/MS. Biomedical chromatography : BMC. 2021 Academic Article GET IT
-
Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
Journal of medicinal chemistry.
2021
Academic Article
GET IT
Times cited: 10 -
Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth.
Bioorganic & medicinal chemistry.
2020
Academic Article
GET IT
Times cited: 2 -
Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents.
Bioorganic & medicinal chemistry.
2019
Academic Article
GET IT
Times cited: 4 -
A quantitative LC-MS/MS method for determination of a small molecule agonist of EphA2 in mouse plasma and brain tissue.
Biomedical chromatography : BMC.
2019
Academic Article
GET IT
Times cited: 2